arrow
J

John D. Crispino

St Jude Children's Research Hospital
H指数:67
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Aberrant thymic architecture and enhanced interferon signaling in Down syndrome

唐氏综合征中异常胸腺结构与增强的干扰素信号通路

2026-10-290
OAAI
DCAF7 regulates hematopoietic stem cell function and differentiation through polycomb repressive complex 1 modulation

DCAF7通过Polycomb抑制复合物1的调控调节造血干细胞功能和分化

2026-10-030
OA
The effect of cohesin mutations on HLA-class II expression in the myeloid leukemia of Down syndrome
Leukemia
IF13.4
2026-07-210
OA
RPS19 and RPL5 haploinsufficient models reveal divergent ribosomal subunit controls of fetal hematopoiesis

RPS19和RPL5单倍不足模型揭示了胎儿造血中核糖体亚基控制的差异性

2026-04-080
OA
FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndrome

FBXO11抑制重塑以NPM1为中心的相互作用网络,影响骨髓增生异常综合征的进展

2026-01-160
OA
Loss of Function Mouse Models Reveal a Novel Regulatory Function for ULK1 in Myeloproliferative Neoplasms

功能缺失小鼠模型揭示ULK1在骨髓增殖性肿瘤中的新型调控功能

2025-07-230
PRE
Disruption of cotranscriptional splicing suggests RBM39 is a therapeutic target in acute lymphoblastic leukemia

共转录剪接的破坏表明RBM39是急性淋巴细胞白血病中的治疗靶点

BLOOD
IF23.1
2024-12-050
PRE
Loss of Cystathionine-β-Synthase Activity Results in Increased Oxidative Phosphorylation and Cytarabine Resistance in Myeloid Leukemia Associated with Down Syndrome

胱硫醚-β-合酶活性丧失导致唐氏综合征相关髓系白血病中氧化磷酸化增加和阿糖胞苷耐药性。

BLOOD
IF23.1
2024-11-050
PRE
KMT2A-Rearranged ALL Requires DYRK1A for Regulation of ERK Signaling and Cell Proliferation

KMT2A-Rearranged ALL需要DYRK1A来调控ERK信号通路和细胞增殖

BLOOD
IF23.1
2024-11-050
PRE
Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia
2024-02-295
OAAI